Pharmaceuticals

Influenza Vaccines Market to Reach $12.13 Billion by 2029, Growing at a CAGR of 7.6%

November 9, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Influenza Vaccines Industry In 2025?

The influenza vaccines market has experienced substantial growth in recent years. It is forecast to grow from $8.5 billion in 2024 to $9.04 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.3%. The growth observed in the past can be attributed to elements such as pandemic preparedness, various public health initiatives, studies on vaccine effectiveness, advice from healthcare professionals, and global influenza surveillance efforts.

The influenza vaccines market is projected to experience substantial expansion over the upcoming years. By 2029, its valuation is anticipated to reach $12.13 billion, progressing at a compound annual growth rate (CAGR) of 7.6%. This anticipated expansion during the forecast period is driven by various factors, including climate and environmental considerations, enhanced healthcare accessibility, the emergence of novel influenza strains, advancements in adjuvants and delivery systems, and increasing healthcare spending. Key developments expected throughout this period encompass the broader adoption of mRNA vaccine technology, an increased emphasis on pediatric immunization, the implementation of seasonal influenza control measures, improved vaccination coverage in developing countries, and the development of customized vaccination approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Influenza Vaccines Industry?

The rising incidences of seasonal influenza are expected to propel the growth of the influenza vaccine market going forward. Seasonal influenza refers to a respiratory illness caused by influenza viruses that typically circulate and cause infections during specific times of the year, usually in the colder months. This increased occurrence has resulted from antigenic drift, population susceptibility, environmental factors, incomplete vaccine coverage, and a lack of universal vaccination. Influenza vaccines help in reducing the incidences of seasonal influenza by providing immunization against the circulating strains of the virus. For example, in November 2023, the Centers for Disease Control and Prevention (CDC) reported that during the 2022-2023 flu season, there were approximately 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Therefore, the rising incidences of seasonal influenza are driving the growth of the influenza vaccines market.

How Is The Influenza Vaccines Market Classified Into Different Segments?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Which Competitive Trends Are Defining The Influenza Vaccines Market Structure?

The influenza vaccine market is increasingly characterized by technologically advanced vaccine production, emerging as a significant area of focus. Companies operating in this sector are employing sophisticated vaccine manufacturing technologies to maintain their market presence. Illustratively, GlaxoSmithKline PLC., a UK-based pharmaceutical and biotechnology company, launched MAPS – Multiple Antigen Presenting System for vaccine development in January 2023. This technology offers an innovative approach to creating effective vaccines to combat bacteria and viruses, proving particularly beneficial for developing vaccines rapidly during an epidemic or pandemic outbreak.

Who Are The Prominent Global Companies Shaping The Influenza Vaccines Market?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

How Do Regional Market Performances Compare Within The Influenza Vaccines Industry?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Influenza Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

Browse Through More Reports Similar to the Global Influenza Vaccines Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795